Global Pharmaceuticals Pakistan is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 388 product registrations across 308 distinct molecules. It is the 15th largest registrant in Pakistan by product count, and ranks 2nd of 178 in Antiinflammatory And Antirheumatic Products. Its portfolio is concentrated in Antiinflammatory And Antirheumatic Products and Other Beta-Lactam, Cephalosporins & Penems. DRAP has issued 124 alerts involving its products.
Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.
Products by Global
286 products matched in our catalogue · showing 80 — each with its observed price and DRAP approved ceiling.
DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.
000 I.U10Ug Polysaccharides Covalently Bound To 20Ug To 32Ug Of Tetanus ToxoidAlbendazoleAlbuterolAlfacalcidolAluminium Hydroxide
Get the full profile for Global
This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.